Iron overload

Understanding iron overload from blood transfusions, the risks and complicaitons.

What is Iron Overload?

Are You At Risk for Iron Overload?

Fact

Osteoporosis and Iron Overload Related Hormonocal Complications

What is Iron Overload?

Are You At Risk for Iron Overload?

Fact

Osteoporosis and Iron Overload Related Hormonocal Complications

What is Iron Overload?

Toxic iron overload is an inevitable consequence of regular blood transfusion. Excess iron cannot be excreted by individuals living with sickle cell disease hence it is deposited in parenchymal tissues and toxicity results in organ damage.

Are You At Risk for Iron Overload?

Anyone who has received more than 10 transfusions is at risk for iron overload.

Fact

Every unit of blood contains about 200-250mg of iron. A single transfusion of two units would provide over 100 times what you would normally get from your diet in a day and is equivalent to 1-2 years’ worth of iron intake!
If you receive frequent blood transfusion, you should be discussing iron overload with your doctor

Osteoporosis and Iron Overload Related Hormonocal Complications

Articles

Discover other Patient & Caregivers Articles

SCAGO

Health Canada Grants Marketing Authorization of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY®

The Sickle Cell Awareness Group of Ontario (SCAGO) is pleased with the news of CASGEVY (Exagamglogene Autotemcel) receiving marketing authorization for the treatment of Sickle Cell and Thalassemia disorders in Canada.

SCAGO

Health Canada Grants Marketing Authorization of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY®

SCAGO

Health Canada Grants Marketing Authorization of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY®

Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA® (voxelotor) From Worldwide Markets

Pfizer Inc. announced today that it is voluntarily withdrawing all lots of OXBRYTA ® (voxelotor) for the treatment of sickle cell disease (SCD) at this time, in all markets where it is approved.

Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA® (voxelotor) From Worldwide Markets

Pfizer Inc. announced today that it is voluntarily withdrawing all lots of OXBRYTA ® (voxelotor) for the treatment of sickle cell disease (SCD) at this time, in all markets where it is approved.

Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA® (voxelotor) From Worldwide Markets

Pfizer Inc. announced today that it is voluntarily withdrawing all lots of OXBRYTA ® (voxelotor) for the treatment of sickle cell disease (SCD) at this time, in all markets where it is approved.

Youth in Pain

Short-Acting Opioid Analgesics for Pain Management

Youth in Pain

Short-Acting Opioid Analgesics for Pain Management

Youth in Pain

Short-Acting Opioid Analgesics for Pain Management

Jacob Pendergrast, MD, FRCPC

Blood Transfusion in Sickle Cell Disease

Improving the knowledge of peers and families about blood transfusion in sickle cell disease

Jacob Pendergrast, MD, FRCPC

Blood Transfusion in Sickle Cell Disease

Improving the knowledge of peers and families about blood transfusion in sickle cell disease

Jacob Pendergrast, MD, FRCPC

Blood Transfusion in Sickle Cell Disease

Improving the knowledge of peers and families about blood transfusion in sickle cell disease

Dr. Robert Klaassen

Pain Management

The Role of Parents & Family Members in sickle cell disease pain management

Dr. Robert Klaassen

Pain Management

The Role of Parents & Family Members in sickle cell disease pain management

Dr. Robert Klaassen

Pain Management

The Role of Parents & Family Members in sickle cell disease pain management

Dr. Julie Beaulac, Ph.D., C. Psych.

Adherence to treatment

Improving care and treatment by utilising informed decision making based on pateint preferences and best practices.

Dr. Julie Beaulac, Ph.D., C. Psych.

Adherence to treatment

Improving care and treatment by utilising informed decision making based on pateint preferences and best practices.

Dr. Julie Beaulac, Ph.D., C. Psych.

Adherence to treatment

Improving care and treatment by utilising informed decision making based on pateint preferences and best practices.

Quick Links

Home

Get Involved

SCAGO Online

Job Openings

Location

Address: 235-415 Oakdale Rd. North York, ON M3N 1W7

Phone: GTA: 416-745-4267

Email: info@sicklecellanemia.ca

Got a Question?

Want to Support Us?

Donate Now

Quick Links

Home

Get Involved

SCAGO Online

Job Openings

Location

Address: 235-415 Oakdale Rd.

North York, ON M3N 1W7

Phone: 416-745-4267

Email: info@sicklecellanemia.ca

Got a Question?

Want to Support Us?

Donate Now

Quick Links

Home

Get Involved

SCAGO Online

Job Openings

Location

Address: 235-415 Oakdale Rd. North York, ON M3N 1W7

Phone: 416-745-4267

Email: info@sicklecellanemia.ca

Got a Question?

Want to Support Us?

Donate Now

Iron overload

Iron overload

Iron overload

Table of contents

Table of contents

What is Iron Overload?

What is Iron Overload?

Are You At Risk for Iron Overload?

Are You At Risk for Iron Overload?

Fact

Fact

Osteoporosis and Iron Overload Related Hormonocal Complications

Discover other Patient & Caregivers Articles

Discover other Patient & Caregivers Articles

Health Canada Grants Marketing Authorization of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY®

Health Canada Grants Marketing Authorization of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY®

Health Canada Grants Marketing Authorization of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY®

Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA® (voxelotor) From Worldwide Markets

Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA® (voxelotor) From Worldwide Markets

Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA® (voxelotor) From Worldwide Markets

Short-Acting Opioid Analgesics for Pain Management

Short-Acting Opioid Analgesics for Pain Management

Short-Acting Opioid Analgesics for Pain Management

Blood Transfusion in Sickle Cell Disease

Blood Transfusion in Sickle Cell Disease

Blood Transfusion in Sickle Cell Disease

Pain Management

Pain Management

Pain Management

Adherence to treatment

Adherence to treatment

Adherence to treatment